| 697548 |
NEURO-ONCOLOGY |
LGG-08. TREATMENT OUTCOMES AND TOLERABILITY OF TRAMETINIB IN PROGRESSIVE CIRCUMSCRIBED LOW-GRADE GLIOMAS |
2021-06-01 |
10.1093/neuonc/noab090.132 |
Hanzlik Emily, Archambault Bridget, Dairi Mays, Schroeder Kristin, Patel Mallika, Lipp Eric S, Boucree Song, Peters Katherine, Ashley David, Landi Daniel |
| 697547 |
NEURO-ONCOLOGY |
IMMU-16. TARGETING GLYPICAN 2 (GPC2) ON PEDIATRIC MALIGNANT BRAIN TUMORS WITH MRNA CAR T CELLS |
2021-06-01 |
10.1093/neuonc/noab090.123 |
Foster Jessica, Griffin Crystal, Stern Allison, Brimley Cameron, Buongervino Samantha, Storm Phillip, Barrett David, Maris John, Resnick Adam, Bosse Kristopher |
| 697546 |
NEURO-ONCOLOGY |
EMBR-10. INOSITOL TREATMENT INHIBITS MEDULLOBLASTOMA THROUGH SUPPRESSION OF EPIGENETIC-DRIVEN METABOLIC ADAPTATION |
2021-06-01 |
10.1093/neuonc/noab090.028 |
Badodi Sara, Pomella Nicola, Zhang Xinyu, Morrison Gillian, Pollard Steve M, Bennett Christopher D, Clifford Steven C, Peet Andrew, Marino Silvia |
| 697545 |
NEURO-ONCOLOGY |
EPEN-08. THE TREM1 POSITIVE HYPOXIC MYELOID SUBPOPULATION IN POSTERIOR FOSSA EPENDYMOMA |
2021-06-01 |
10.1093/neuonc/noab090.058 |
Willard Nicholas, Donson Andrew, Ritzmann Timothy, Grundy Richard, Jackson Andrew, Hankinson Todd, Griesinger Andrea, Foreman Nicholas |
| 697544 |
NEURO-ONCOLOGY |
EMBR-22. RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA |
2021-06-01 |
10.1093/neuonc/noab090.040 |
Bakhshinyan David, Adile Ashley A, Venugopal Chitra, Brown Kevin, Chan Katherine, Qazi Maleeha A, Chokshi Chirayu, Gwynne William D, Tieu David, Moffat Jason, Singh Sheila |
| 697543 |
NEURO-ONCOLOGY |
OMIC-08. COMPOUND HETEROZYGOSITY OF POLE AND PMS2 LEADS TO CMMRD-LIKE PHENOTYPE- “POLYNCH” SYNDROME |
2021-06-01 |
10.1093/neuonc/noab090.155 |
Michaeli Orli, Ladany Hagay, Maruvka Yosef E, Erez Ayelet, Shachar Shay Ben, Izraeli Shai, Goldberg Yael, Toledano Helen |
| 697542 |
NEURO-ONCOLOGY |
RARE-02. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA |
2021-06-01 |
10.1093/neuonc/noab090.163 |
Khan Aaminah, Gamble Laura, Upton Dannielle, Yu Denise, Pandher Ruby, Mayoh Chelsea, Burns Mark R, Norris Murray D, Haber Michelle, Tsoli Maria, Ziegler David S |
| 697541 |
NEURO-ONCOLOGY |
HGG-14. ACT001 – A PROMISING THERAPEUTIC FOR DIFFUSE INTRINSIC PONTINE GLIOMAS |
2021-06-01 |
10.1093/neuonc/noab090.080 |
Upton Dannielle, George Sandra, Liu Jie, Cai Dongpo, Su Steven Yung-Chang, Manoharan Neevika, Foresto Steve, Hassall Tim, Tsoli Maria, Ziegler David |
| 697540 |
NEURO-ONCOLOGY |
TMOD-01. A PROGNOSTIC NOMOGRAM MODEL AND ONLINE SOFTWARE FOR PATIENTS WITH NEWLY DIAGNOSED LOWER-GRADE GLIOMAS |
2021-06-01 |
10.1093/neuonc/noab090.142 |
Han Mingzhi |
| 697539 |
NEURO-ONCOLOGY |
HGG-11. LEPTOMENINGEAL DISEASE AND TUMOR DISSEMINATION ALONG CSF PATHWAYS IN A MURINE DIPG MODEL: IMPLICATIONS FOR STUDY OF THE TUMOR-CSF-EPENDYMAL MICROENVIRONMENT |
2021-06-01 |
10.1093/neuonc/noab090.077 |
Pan Shelei, Ye Dezhuang, Yue Yimei, Yang Lihua, Pacia Christopher, Dahiya Sonika, Limbrick David, Rubin Joshua, Chen Hong, Strahle Jennifer |
